Chat with us, powered by LiveChat

Loading...

Energy-based Cancer Treatment Market Report

RA00105

Energy-based Cancer Treatment Market, by Treatment Type (Invasive, Non-invasive), Source of Energy (Proton Beam, X-Rays, Electron Beam, Gamma Rays), Application (Breast Cancer, Cervical Cancer, Prostate Cancer, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

RA00105

Pages: NA

Feb 2020

COVID-19

pandemic has shown to have an enormous impact on most
industries.

Click Here to access our comprehensive analysis of the

Impact of covid-19 on Energy-based Cancer Treatment Market

Energy-based Cancer Treatment Market Overview 2026:

Energy-based cancer treatment systems use radioactive beams such as gamma rays, x-rays and others for the treatment of the cancer cells by damaging the cell DNA. These systems target the specific molecules in the cancer cells and stop the spreading and growing.

Driving Factors of Energy-based Cancer Treatment Market:

Growing number of cancer patients is significantly driving the growth of the energy-based cancer treatment market 

Increasing number of cancer patients globally coupled with a rise in the adoption of energy-based treatment methods for the cancer are major driving factors for the energy-based cancer treatment market. As per report published by World Health Organization (WHO), the number of cancer patients has increased up to 18.1 million and there have been 9.6 million cancer related deaths in 2018. This factor is increasing the demand of energy-based cancer treatment systems and is expected to drive the growth of the market. Technological developments and advancements of radioactive treatment instruments like stereotactic body radiation therapy and image-guided radiation therapy are estimated to propel the growth of the market. In addition, growing government initiatives about cancer awareness, implementation of the energy-based therapies and increasing the healthcare expenses are projected to drive the growth of the market.   

Continuous increase in the developments in the cancer treatment methods are projected to create investment opportunity for the energy-based cancer treatment market growth

Growing advancements in non-invasive treatment are expected to generate substantial revenue and is projected to create significant growth opportunities in the global energy-based cancer treatment market. Researchers have developed a novel system for the treatment of cancer, which is non-invasive cancer therapy using targeted single walled carbon nanotubes. These carbon nanotubes are unique and they powerfully absorb near infrared light and, heating and killing cancer cells without damaging healthy cells. This factor is projected to drive the growth of the energy-based cancer treatment market in the near future. 

Non-invasive treatment type is estimated to be most lucrative in the projected time

Non-invasive treatment is projected to experience a significant growth during the forecast period. This growth is mainly owing to its effectiveness in finding the precise location of the cancer cells and killing them without destroying healthy cells. Non-invasive procedure does not require any device to be inserted into the human body. 
Invasive treatment is anticipated to experience healthy growth during the forecast time. This growth is mainly because of increase in the use of invasive methods for cervical and breast cancer treatment. 

X-Rays was valued highest market size and is estimated to most lucrative till the end of 2026

X-Rays energy source accounted for the majority of the market share in terms of revenue in 2018 and is estimated to grow at a significant rate during the forecast time. This is majorly because X-Rays are the most common energy source for cancer treatment and detection devices due to features like being painless and quality of treatment. In addition, X-Rays radiation therapy has minimal side effects on the DNA than chemotherapy and this is projected to drive the growth of the market.

Gamma rays are extremely energetic electromagnetic radiation similar to X-Rays. Gamma rays are widely used in the radiotherapy to detect and treat cancer. Gamma rays will minimize the cell damage from cancer, which will drive the market growth in the coming years.

Breast cancer segment accounted for the highest market share and is projected to grow at a healthy rate in the estimated time

Prostate and cervical cancer applications are anticipated to show a notable growth in the forecast time, due to increase in the prevalence of prostate and cervical cancer among the people. According to American Cancer Society, about 4,290 American women will succumb to cancer by 2020 out of 13,800 new cervical cancer cases. This is expected to impact the use of energy-based cancer treatment systems for the treatment of cervical cancer. 

Breast cancer application held the largest global energy-based cancer treatment market size in 2018, and is anticipated to grow at a faster rate during the projected period. This growth is because of wide usage of energy-based cancer treatment systems for the treatment of breast cancer across the world, since breast cancer is the most common cancer related disease among women. Furthermore, growing support for breast cancer research funding and awareness has created developments and increase in the adoption of innovative therapies which are impacting the demand for the energy-based cancer treatment market in the coming years. Due to the advanced systems in the cancer diagnosis, the number of deaths related to cancer are steadily declining because of early detection, awareness about the occurrence of disease and others.    

Asia-Pacific region will have huge opportunities for the investors to grow in the estimated time

Asia-Pacific region will witness to grow at a rapid pace, which is estimated to create huge investment opportunities for the manufacturers and is anticipated to generate significant revenue in the projected period. This expected growth in the market is majorly owing to increasing number of cancer patients in the Asia-Pacific region. In addition, growing government initiatives on cancer awareness and control of cancer disease are projected to drive the market growth in this region. For instance, according to Indian Counsel of Medical Research (ICMR), 0.32 million people died because of tobacco consumption in 2018 and around 2,500 people die every day because of tobacco related diseases in India.

North America led the majority of the global energy-based cancer treatment market share in 2018 and is predicted to continue its dominance on the market share in the forecast period. This dominance is attributed to advanced healthcare infrastructure and prevalence of cancer disease in the North America region. Moreover, the existence of major manufacturers in this region is anticipated to boost the growth of the market in the coming years. As per American Cancer Society, around 0.60 million of people deaths are expected out of 1.80 million new cancer patients in the U.S.

To explore more about energy-based cancer treatment market, Pre-Book and avail Discount on this Report : https://www.researchdive.com/connect-to-analyst/105

Key Participants in global Energy-based Cancer Treatment Market:

Key Participants in global Energy-based Cancer Treatment Market	 

 

R&D investments and mergers & acquisitions are the major strategies followed by the key participants

Source: Research Dive Analysis

The major energy-based cancer treatment market players are Mevion Medical Systems, Hitachi, Ltd., Accuray Incorporated, IBA Worldwide, Isoray Inc., Elekta AB (pub), Siemens Healthcare Private Limited, ProTom International, RANOR, Inc., NTP Radioisotopes SOC Ltd and among others. These key players are continuously rising their determination towards new technology introduction, product developments, upgradation of existed technologies and R&D investments to gain highest market size in the overall energy-based cancer treatment industry.
 

 

 

  

Aspect

Particulars

  Historical Market Estimations

  2018-2019

  Base Year for Market Estimation

  2018

  Forecast timeline for Market Projection

  2019-2026

  Geographical Scope

  North America, Europe, Asia-Pacific, LAMEA

  Segmentation by Treatment Type

  • Invasive
  • Non-invasive

  Segmentation by Source of Energy

  • Proton Beam
  • X-Rays
  • Electron Beam
  • Gamma Rays

  Segmentation by Application

  • Breast Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Others

  Key Countries Covered

U.S., Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, and Saudi Arabia

  Key Companies Profiled

  • Mevion Medical Systems
  • Hitachi, Ltd.
  • Accuray Incorporated
  • IBA Worldwide
  • Isoray Inc.
  • Elekta AB (pub)
  • Siemens Healthcare Private Limited
  • ProTom International
  • RANOR, Inc.
  • NTP Radioisotopes SOC Ltd

Source: Research Dive Analysis


FREQUENTLY ASKED QUESTIONS?
 

A. Mevion Medical Systems, IBA Worldwide, Siemens Healthcare Private Limited, ProTom International and NTP Radioisotopes SOC Ltd are some of the key players in the global connected motorcycles market.

A. Asia-Pacific possesses great investment opportunities for the investors to witness the most promising growth in the coming years.

A. R&D investments and collaborations & partnerships are the key strategies opted by the operating companies in this market.

A. Mevion Medical Systems, Siemens Healthcare Private Limited and NTP Radioisotopes SOC Ltd are investing more on R&D activities for developing new products and technologies

Research Methodology

Purchase Options

Enquire To Buy

Personalize this research

  • Triangulate with your own data
  • Get Data as per your format and defination
  • Get a deeper dive on a specific application, geography, customer or competitor
10% Off on Customization
Contact Us

Customers Also Viewed